• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解和调节单克隆抗体制剂的乳光和黏度。

Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.

机构信息

Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado, USA.

出版信息

J Pharm Sci. 2010 Jan;99(1):82-93. doi: 10.1002/jps.21797.

DOI:10.1002/jps.21797
PMID:19475558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3927449/
Abstract

Opalescence and high viscosities can pose challenges for high concentration formulation of antibodies. Both phenomena result from protein-protein intermolecular interactions that can be modulated with solution ionic strength. We studied a therapeutic monoclonal antibody (mAb) that exhibits high viscosity in solutions at low ionic strength ( approximately 20 cP at 90 mg/mL and 23 degrees C) and significant opalescence at isotonic ionic strength (approximately 100 nephelometric turbidity units at 90 mg/mL and 23 degrees C). The intermolecular interactions responsible for these effects were characterized using membrane osmometry, static light scattering, and zeta potential measurements. The net protein-protein interactions were repulsive at low ionic strength ( approximately 4 mM) and attractive at isotonic ionic strengths. The high viscosities are attributed to electroviscous forces at low ionic strength and the significant opalescence at isotonic ionic strength is correlated with attractive antibody interactions. Furthermore, there appears to be a connection to critical phenomena and it is suggested that the extent of opalescence is dependent on the proximity to the critical point. We demonstrate that by balancing the repulsive and attractive forces via intermediate ionic strengths and by increasing the mAb concentration above the apparent critical concentration both opalescence and viscosity can be simultaneously minimized.

摘要

对于高浓度的抗体制剂来说,乳光和高黏度可能会带来挑战。这两种现象都源于蛋白质-蛋白质分子间的相互作用,可以通过溶液离子强度来调节。我们研究了一种治疗性单克隆抗体(mAb),该抗体在低离子强度的溶液中(90mg/ml 和 23°C 时约为 20cP)表现出高黏度,在等渗离子强度下(90mg/ml 和 23°C 时约为 100 奈光浊度单位)表现出显著的乳光。使用膜渗透压计、静态光散射和zeta 电位测量来表征这些效应的分子间相互作用。在低离子强度(约 4mM)下,净蛋白-蛋白相互作用是排斥的,而在等渗离子强度下是吸引的。低离子强度下的高黏度归因于电动黏度力,等渗离子强度下的显著乳光与抗体的吸引力相互作用有关。此外,似乎与临界现象有关,并且表明乳光的程度取决于接近临界点的程度。我们证明,通过在中间离子强度下平衡排斥力和吸引力,以及通过将 mAb 浓度提高到表观临界浓度以上,可以同时最小化乳光和黏度。

相似文献

1
Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.理解和调节单克隆抗体制剂的乳光和黏度。
J Pharm Sci. 2010 Jan;99(1):82-93. doi: 10.1002/jps.21797.
2
Opalescence in monoclonal antibody solutions and its correlation with intermolecular interactions in dilute and concentrated solutions.单克隆抗体溶液中的乳光现象及其与稀溶液和浓溶液中分子间相互作用的相关性。
J Pharm Sci. 2015 Apr;104(4):1263-74. doi: 10.1002/jps.24326. Epub 2014 Dec 30.
3
Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.不同单克隆抗体高浓度溶液黏度的影响因素。
J Pharm Sci. 2010 Dec;99(12):4812-29. doi: 10.1002/jps.22190.
4
How Well Do Low- and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?低浓度和高浓度蛋白相互作用在多大程度上可以预测单克隆抗体的溶液黏度?
J Pharm Sci. 2019 Jan;108(1):142-154. doi: 10.1016/j.xphs.2018.07.007. Epub 2018 Jul 12.
5
Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.蛋白质溶液中乳光及液-液相分离的药学视角
Mol Pharm. 2016 May 2;13(5):1431-44. doi: 10.1021/acs.molpharmaceut.5b00937. Epub 2016 Apr 5.
6
Phase separation of an IgG1 antibody solution under a low ionic strength condition.在低离子强度条件下 IgG1 抗体溶液的相分离。
Pharm Res. 2010 Jul;27(7):1348-60. doi: 10.1007/s11095-010-0125-7. Epub 2010 Apr 17.
7
Specific interactions in high concentration antibody solutions resulting in high viscosity.高浓度抗体溶液中的特定相互作用导致高粘度。
J Pharm Sci. 2010 Mar;99(3):1152-68. doi: 10.1002/jps.21898.
8
The role of electrostatics in protein-protein interactions of a monoclonal antibody.静电在单克隆抗体蛋白质-蛋白质相互作用中的作用。
Mol Pharm. 2014 Jul 7;11(7):2475-89. doi: 10.1021/mp5002334. Epub 2014 Jun 18.
9
The Effect of Low Ionic Strength on Diffusion and Viscosity of Monoclonal Antibodies.低离子强度对单克隆抗体扩散和黏度的影响。
Mol Pharm. 2018 Aug 6;15(8):3133-3142. doi: 10.1021/acs.molpharmaceut.8b00210. Epub 2018 Jul 24.
10
Opalescence of an IgG2 monoclonal antibody solution as it relates to liquid-liquid phase separation.IgG2 单克隆抗体溶液的乳光与其液-液相分离的关系。
J Pharm Sci. 2011 Nov;100(11):4587-96. doi: 10.1002/jps.22650. Epub 2011 Jun 2.

引用本文的文献

1
Growth of Clusters toward Liquid-Liquid Phase Separation of Monoclonal Antibodies as Characterized by Small-Angle X-ray Scattering and Molecular Dynamics Simulation.通过小角X射线散射和分子动力学模拟表征单克隆抗体向液-液相分离的聚集体生长
J Phys Chem B. 2025 Mar 20;129(11):2856-2871. doi: 10.1021/acs.jpcb.4c07064. Epub 2025 Mar 7.
2
A scaling relationship between thermodynamic and hydrodynamic interactions in protein solutions.蛋白质溶液中热力学和流体动力学相互作用的标度关系。
Biophys J. 2024 Nov 19;123(22):3871-3883. doi: 10.1016/j.bpj.2024.09.032. Epub 2024 Oct 2.
3
Portable Microfluidic Viscometer for Formulation Development and in Situ Quality Control of Protein and Antibody Solutions.便携式微流控黏度计在蛋白质和抗体溶液的制剂开发和原位质量控制中的应用。
Anal Chem. 2024 Aug 13;96(32):13185-13190. doi: 10.1021/acs.analchem.4c02099. Epub 2024 Aug 2.
4
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning.通过可解释的机器学习优化治疗性抗体以减少自身聚集和非特异性结合。
Nat Biomed Eng. 2024 Jan;8(1):45-56. doi: 10.1038/s41551-023-01074-6. Epub 2023 Sep 4.
5
A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations.美国批准的商业化高浓度抗体药物产品的系统评价:制剂组成、剂型设计和初级包装考虑因素。
MAbs. 2023 Jan-Dec;15(1):2205540. doi: 10.1080/19420862.2023.2205540.
6
Blueprint for antibody biologics developability.抗体生物制剂开发蓝图。
MAbs. 2023 Jan-Dec;15(1):2185924. doi: 10.1080/19420862.2023.2185924.
7
Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction.可逆抗体自缔合的表征与建模为行为、预测和校正提供了见解。
Antibodies (Basel). 2021 Feb 15;10(1):8. doi: 10.3390/antib10010008.
8
Particle Detection and Characterization for Biopharmaceutical Applications: Current Principles of Established and Alternative Techniques.生物制药应用中的颗粒检测与表征:现有技术和替代技术的当前原理
Pharmaceutics. 2020 Nov 19;12(11):1112. doi: 10.3390/pharmaceutics12111112.
9
A single molecular descriptor to predict solution behavior of therapeutic antibodies.一种用于预测治疗性抗体溶液行为的单一分子描述符。
Sci Adv. 2020 Aug 5;6(32):eabb0372. doi: 10.1126/sciadv.abb0372. eCollection 2020 Aug.
10
Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids.电粘性效应在高浓度蛋白质制剂开发中对粘度的影响:来自非蛋白质带电胶体的经验教训。
Int J Pharm X. 2018 Dec 24;1:100002. doi: 10.1016/j.ijpx.2018.100002. eCollection 2019 Dec.

本文引用的文献

1
Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity.由Fab-Fab相互作用介导的浓缩单克隆抗体溶液的可逆自缔合,这种相互作用会影响溶液粘度。
J Pharm Sci. 2008 Oct;97(10):4219-27. doi: 10.1002/jps.21322.
2
Effective hard particle model for the osmotic pressure of highly concentrated binary protein solutions.高浓度二元蛋白质溶液渗透压的有效硬粒子模型
Biophys J. 2008 Apr 1;94(7):L57-9. doi: 10.1529/biophysj.107.128033. Epub 2008 Jan 22.
3
Protein phase behavior in aqueous solutions: crystallization, liquid-liquid phase separation, gels, and aggregates.蛋白质在水溶液中的相行为:结晶、液-液相分离、凝胶和聚集体。
Biophys J. 2008 Jan 15;94(2):570-83. doi: 10.1529/biophysj.107.116152.
4
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.重组人白细胞介素-1受体拮抗剂的高浓度制剂:II. 聚集动力学
J Pharm Sci. 2008 Aug;97(8):3005-21. doi: 10.1002/jps.21205.
5
The effective hard particle model provides a simple, robust, and broadly applicable description of nonideal behavior in concentrated solutions of bovine serum albumin and other nonassociating proteins.有效硬粒子模型为牛血清白蛋白及其他非缔合蛋白浓溶液中的非理想行为提供了一种简单、稳健且广泛适用的描述。
J Pharm Sci. 2007 Dec;96(12):3466-9. doi: 10.1002/jps.20964.
6
Fast determination of conditions for maximum dynamic capacity in cation-exchange chromatography of human monoclonal antibodies.快速确定人源单克隆抗体阳离子交换色谱中最大动态容量的条件
J Chromatogr A. 2007 Aug 17;1161(1-2):29-35. doi: 10.1016/j.chroma.2007.03.114. Epub 2007 Apr 4.
7
Application of high-frequency rheology measurements for analyzing protein-protein interactions in high protein concentration solutions using a model monoclonal antibody (IgG2).使用模型单克隆抗体(IgG2),高频流变学测量在分析高蛋白浓度溶液中蛋白质-蛋白质相互作用方面的应用。
J Pharm Sci. 2006 Sep;95(9):1967-83. doi: 10.1002/jps.20663.
8
Light scattering and phase behavior of lysozyme-poly(ethylene glycol) mixtures.溶菌酶 - 聚乙二醇混合物的光散射和相行为
Phys Rev Lett. 2006 Mar 3;96(8):087803. doi: 10.1103/PhysRevLett.96.087803.
9
Negative second virial coefficients as predictors of protein crystal growth: evidence from sedimentation equilibrium studies that refutes the designation of those light scattering parameters as osmotic virial coefficients.负第二维里系数作为蛋白质晶体生长的预测指标:沉降平衡研究的证据反驳了将那些光散射参数指定为渗透维里系数的做法。
Biophys Chem. 2006 Mar 20;120(2):106-13. doi: 10.1016/j.bpc.2005.10.003. Epub 2005 Nov 21.
10
Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.可逆的自缔合作用增加了浓缩单克隆抗体在水溶液中的粘度。
J Pharm Sci. 2005 Sep;94(9):1928-40. doi: 10.1002/jps.20347.